Y. Mizukami et al., DIFFERENTIAL (HA-, K- AND N-) RAS P21 EXPRESSION IN BENIGN AND MALIGNANT HUMAN THYROID-TUMORS - AN IMMUNOHISTOCHEMICAL STUDY, Anticancer research, 15(3), 1995, pp. 755-759
An immunohistochemical study of 24 thyroid carcinomas, 10 thyroid aden
omas and 10 normal thyroids was performed using monoclonal antibodies
directed against each of the three members of ras p21s; Ha-, K- and N-
ras p21. Normal thyroids showed a negative staining for all of the thr
ee ms p21s. The expressional levels of the three ras p21s were various
in each benign and malignant thyroid tumor; but a higher expression o
f Ha- and N-ras p21 and a lower or negative expression of K-ras p21 wa
s a common finding in thyroid tumors of all histologic categories. The
re were no correlations between the expressional levels of ms p21s and
the histologic subtypes, tumor size or lymph node status in the thyro
id carcinomas.